Deep Breathe picked for NATO DIANA Mission Track to advance ATLAS

Deep Breathe has been selected as one of 15 companies for NATO DIANA’s Mission Track, putting its AI-guided ultrasound platform ATLAS on a path toward field validation and wider military use. The move highlights growing demand for front-line diagnostic tools that can help medics assess chest and abdominal injuries in contested environments.

Why it matters: - NATO DIANA’s Mission Track is reserved for technologies that show clear defence demand and fit Allied operational needs. - ATLAS could help medics make faster decisions on treatment, triage and evacuation when patients are held forward for hours or days. - The platform is aimed at giving non-expert users access to diagnostic capability that has traditionally sat with physicians and higher levels of care.

What happened: - Deep Breathe was selected as one of 15 companies for NATO DIANA’s Mission Track. - The London, Ontario-based company is advancing ATLAS, the AI Tactical Assessment System. - The announcement says ATLAS uses AI-guided handheld ultrasound to assess life-threatening chest and abdominal injuries. - Deep Breathe said the selection supports a shift from technology development toward operational deployment.

The details: - ATLAS is backed by 19 peer-reviewed publications and 8 patent families. - Over the last six months, Deep Breathe worked with military end users through exercises in Canada, Estonia, Spain, the United Kingdom and the United States. - Deep Breathe also completed its first military sale during that period. - The company’s founder, Dr. Rob Arntfield, said ATLAS brings diagnostic expertise to medics at the front line. - Dr. Arntfield said the system helps speed decisions on treatment, triage and evacuation.

Between the lines: - The NATO DIANA selection suggests ATLAS has moved beyond a lab-stage concept and into a defense pathway focused on validation and adoption. - The mix of exercises, early sales and peer-reviewed support points to a product being tested for real-world military use rather than civilian-only deployment. - The emphasis on handheld ultrasound reflects a broader need for portable tools that work when access to specialists and advanced imaging is limited.

What's next: - Mission Track will focus on field validation and commercialization. - Deep Breathe will work toward broader operational adoption across the NATO Alliance. - Continued military testing will likely shape how ATLAS is used in future casualty-care scenarios.

The bottom line: - Deep Breathe now has a NATO-backed path to prove ATLAS can deliver faster front-line diagnosis where time, space and expertise are limited.